Antimicrobial Resistance Pricing and Reimbursement Scoping Study Final Report

This project was commissioned under the 2020-21 Budget measure for implementation of Australia’s Antimicrobial Resistance Strategy – 2020 and Beyond. The report was delivered in August 2022. This publication is provided for general information only. The report should be considered as a foundation for further development and not as Government policy endorsement.

• General public
• Objective 3: Greater engagement in the combat against resistance
• Objective 1: Clear governance for antimicrobial resistance initiatives
• Objective 7: Strengthen global collaboration and partnerships
• Objective 6: A strong collaborative research agenda across all sectors